About BioSeek

BioSeek is committed to improving the success rate of pharmaceutical development by integrating human biology from the early stages of drug discovery through preclinical development.  Our BioMAP^® systems incorporate predictive human cell-based disease models that generate uniquely informative biological activity signatures for each potential drug, yielding actionable data to drive the selection and development of new drug candidates.  We are leveraging our BioMAP technology in collaborations to enhance the productivity of our pharmaceutical partners’ pipelines, and in our internal programs to identify promising compounds for proprietary development in the fields of inflammation, cardiovascular disease and related indications.  Our vision is to harness the predictive power of integrative cell systems biology to improve human health.